Does AMBRISENTAN Cause Application site vesicles? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Application site vesicles have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.0% of all adverse event reports for AMBRISENTAN.
9
Reports of Application site vesicles with AMBRISENTAN
0.0%
of all AMBRISENTAN reports
0
Deaths
6
Hospitalizations
How Dangerous Is Application site vesicles From AMBRISENTAN?
Of the 9 reports, 6 (66.7%) required hospitalization.
Is Application site vesicles Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Application site vesicles?
INGENOL MEBUTATE (843)
BUPRENORPHINE (700)
SUMATRIPTAN (262)
NICOTINE (241)
MINOXIDIL (188)
ESTRADIOL (179)
FENTANYL (170)
PICATO (139)
DICLOFENAC (115)
CHLORHEXIDINE\ISOPROPYL ALCOHOL (80)
Which AMBRISENTAN Alternatives Have Lower Application site vesicles Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE